SKI Market

Indian Indices

Nifty

24,712.05 -255.70
(-1.02%)

Sensex

80,786.54 -849.37
( -1.04%)

Bank Nifty

54,450.45 -688.85
( -1.25%)

Nifty IT

36,063.20 -216.85
( -0.60%)

Global Indices

Nasdaq

45,450.55 147.07
(0.32%)

Dow Jones

6,488.44 28.12
(0.44%)

Hang Seng

42,514.95 120.55
(0.28%)

Nikkei 225

9,255.50 -10.30
(-0.11%)

Forex

USD-INR

87.51 0.16
(0.19%)

EUR-INR

102.17 -0.20
(-0.19%)

GBP-INR

118.05 -0.04
(-0.04%)

JPY-INR

0.59 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Anuh Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506260

INE489G01022

32.5296137

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANUHPHR

19.01

876.56

EPS(TTM)

Face Value()

Div & Yield %

4.6

0.86

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	661.51	647.00	527.49	486.65	431.96	306.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	661.51	647.00	527.49	486.65	431.96	306.96
Other Income	9.46	12.10	6.11	5.20	10.54	4.21
Stock Adjustments	2.45	15.24	-13.48	4.86	-2.31	13.51
Total Income	673.42	674.34	520.12	496.71	440.19	324.68
EXPENDITURE :
Raw Materials	501.82	501.90	388.00	382.54	327.49	243.67
Power & Fuel Cost	12.35	12.37	11.02	8.80	8.66	6.31
Employee Cost	23.04	19.39	17.15	15.10	14.29	13.36
Other Manufacturing Expenses	28.62	23.72	19.98	14.91	13.41	11.97
Selling & Administrative Expenses	17.76	15.50	13.28	12.07	11.17	8.90
Miscellaneous Expenses	18.85	13.61	12.77	10.62	9.51	13.02
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	602.43	586.49	462.20	444.04	384.53	297.23
Operating Profit	70.98	87.85	57.92	52.66	55.66	27.45
Interest	1.24	0.96	0.75	1.58	2.03	1.26
Gross Profit	69.74	86.89	57.17	51.08	53.63	26.19
Depreciation	8.74	8.58	9.70	11.96	15.08	7.03
Profit Before Tax	61.00	78.31	47.47	39.12	38.55	19.16
Tax	14.67	18.13	12.12	10.58	9.47	3.54
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.02	0.12	-0.83	-2.02	0.65	1.31
Reported Net Profit	47.35	60.06	36.18	30.56	28.44	14.31
Extraordinary Items	5.96	8.17	3.24	1.97	5.94	1.06
Adjusted Net Profit	41.39	51.89	32.94	28.59	22.50	13.25
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	156.63	113.59	93.18	76.14	53.70	56.01
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	19.53	17.02	15.77	13.52	6.00	16.61
P & L Balance carried down	184.45	156.63	113.59	93.18	76.14	53.70
Dividend	0.00	0.00	0.00	0.00	0.00	6.89
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	30.00	50.00	40.00	35.00	30.00	55.00
Dividend Per Share(Rs)	1.50	2.50	2.00	1.75	1.50	2.75
Earnings Per Share-Unit Curr	9.45	11.98	7.22	6.10	5.67	5.71
Earnings Per Share(Adj)-Unit Curr	4.73	5.99	3.61	3.05	2.84	1.43
Book Value-Unit Curr	65.06	58.11	48.14	42.66	38.04	64.74
Book Value(Adj)-Unit Curr	32.53	29.06	24.07	21.33	19.02	16.19

24,712.05 -255.70 (-1.02%)

80,786.54 -849.37 ( -1.04%)

54,450.45 -688.85 ( -1.25%)

36,063.20 -216.85 ( -0.60%)

45,450.55 147.07 (0.32%)

6,488.44 28.12 (0.44%)

42,514.95 120.55 (0.28%)

9,255.50 -10.30 (-0.11%)

87.51 0.16 (0.19%)

102.17 -0.20 (-0.19%)

118.05 -0.04 (-0.04%)

0.59 0.00 (-0.17%)